Capitalist Harbor
  • Investing
  • Stock
  • Latest News
  • Editor’s Pick
  • Economy
Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.



    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
    Popular Topics
    • Critics slam Mexico’s gentrification protests as xenophobic. Activists say they’re fighting for their human rights
    • EU’s von der Leyen survives parliament confidence vote brought by far-right
    • Share Purchase Plan Offer Booklet
    • Desperate Gaza doctors cram several babies into one incubator as fuel crisis reaches critical point
    • Blaze at Cairo telecommunications building kills 4, disrupts internet, phone
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    Capitalist Harbor
    • Investing
    • Stock
    • Latest News
    • Editor’s Pick
    • Economy
    • Editor's Pick

    EU’s von der Leyen survives parliament confidence vote brought by far-right

    • July 10, 2025
    • admin

    European Commission President Ursula von der Leyen survived a no-confidence vote in the European Parliament on Thursday, brought by mainly far-right lawmakers who alleged she and her team undermined trust in the EU through unlawful actions.

    As expected, the motion failed to get the two-thirds majority it needed to pass. Only 175 members of parliament backed the motion, while 360 voted against and 18 abstained.

    Romanian nationalist Gheorghe Piperea, the lead sponsor of the motion, had criticized among other things the Commission’s refusal to disclose text messages between von der Leyen and the chief executive of vaccine maker Pfizer during the COVID-19 pandemic.

    “The decision-making has become opaque and discretionary, and raises fears of abuse and corruption. The cost of obsessive bureaucracy of the European Union such as (tackling) climate change has been a huge one,” Piperea told the parliament on Monday.

    During the debate on her leadership, von der Leyen defended her record in parliament, rejecting criticism of her management of the pandemic and asserting that her approach ensured equal vaccine access across the EU.

    Although the censure motion had little chance of success, it was a political headache for von der Leyen as her Commission negotiates with US President Donald Trump’s administration to try to prevent steep US tariffs on EU goods.

    It was the first time since 2014 that a Commission president has faced such a motion. Then President Jean-Claude Juncker also survived the vote.

    This post appeared first on cnn.com

    admin

    Previous Article
    • Investing

    Share Purchase Plan Offer Booklet

    • July 9, 2025
    • admin
    View Post
    Next Article
    • Editor's Pick

    Critics slam Mexico’s gentrification protests as xenophobic. Activists say they’re fighting for their human rights

    • July 11, 2025
    • admin
    View Post
    Get Smarter with Your Money – Sign Up for Free Financial Tips!



      Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!
      Popular Topics
      • Critics slam Mexico’s gentrification protests as xenophobic. Activists say they’re fighting for their human rights
      • EU’s von der Leyen survives parliament confidence vote brought by far-right
      • Share Purchase Plan Offer Booklet
      • Desperate Gaza doctors cram several babies into one incubator as fuel crisis reaches critical point
      • Blaze at Cairo telecommunications building kills 4, disrupts internet, phone
      Disclaimer: capitalistharbor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
      • About us
      • Contacts
      • Privacy Policy
      • Terms and Conditions
      • Email Whitelisting

      Input your search keywords and press Enter.